Bodytechmed Receives Domestic Approval for Vitamin D Deficiency Diagnostic Kit...Significantly Reduced Testing Time

[Asia Economy Reporter Lee Gwanju] Bodytech Med announced on the 13th that it has obtained domestic approval from the Ministry of Food and Drug Safety for one diagnostic kit (ichroma™ Vitamin D Neo) that can quickly determine vitamin D deficiency in medical settings.

The approved diagnostic kit can accurately determine vitamin D deficiency within 12 minutes at clinic-level medical institutions, reducing the inconvenience of patient revisits. Compared to the existing product sold for overseas export (30 minutes), the testing time has been significantly reduced, and the specimen type has been expanded from serum and plasma, which require separate purification processes, to whole blood, making testing more convenient.

Additionally, the vitamin D diagnostic kit compatible with Bodytech Med’s fully automated diagnostic device AFIAS (AFIAS Vitamin D Neo) is currently under review by the Ministry of Food and Drug Safety, and the company expects approval soon.

Bodytech Med launched a product capable of determining vitamin D deficiency in 2016 and has been selling it worldwide. Since its launch, it has recorded an average annual sales growth of over 60%. Among domestic manufacturers, it is the only one to hold the Vitamin D Standardization Certification Program (VDSCP) administered by the U.S. Centers for Disease Control and Prevention (CDC).

Choi Eui-yeol, CEO of Bodytech Med, stated, “The ability to quickly determine vitamin D deficiency at clinic-level medical institutions is expected to bring significant changes to the existing diagnostic methods using large equipment,” and added, “The vitamin D diagnostic kit can be diagnosed through our rapid antigen diagnostic devices, which are currently expanding sales in domestic clinics, so we expect a synergistic effect in terms of sales.”

This content was produced with the assistance of AI translation services.